Daniel Fife

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Attention Deficit Hyperactivity Disorder

Community Dwelling

Ejection Fraction

Top Venues

BMC pharmacology & toxicology

Drugs - real world outcomes

Neuropsychopharmacology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Fife, Stephen Fortin, Hong Qiu, Michiyo Yamazaki, Dean Najarian, Erica A Voss
Baseline risk characterization of early versus later adopters of long-acting paliperidone palmitate formulations. Neuropsychopharmacology reports 42 (3) (2022)
Daniel Fife, Clair Blacketer, Karl Knight, James Weaver
Stroke Risk Among Non-Elderly Users of Haloperidol or First-Generation Antipsychotics vs Second-Generation Antipsychotics: A Cohort Study from a US Health Insurance Claims Database. Drugs - real world outcomes 8 (4) (2021)
Marsha A Wilcox, Angelina Villasis-Keever, Anthony G Sena, Christopher Knoll, Daniel Fife
Evaluation of disability in patients exposed to fluoroquinolones. BMC pharmacology & toxicology 21 (1) (2020)
Daniel Fife, M Soledad Cepeda, Alan Baseman, Henry Richards, Peter Hu, H Lynn Starr, Anthony G Sena
Medication changes after switching from CONCERTA® brand methylphenidate HCl to a generic long-acting formulation: A retrospective database study. PloS one 13 (2) (2018)